Drug intelligence / Profile preview

CAMYO-02

Development stage: Preclinical
Lead developer: myNEO Therapeutics
Modality: Nucleic Acid-Directed Small Molecules → Small Molecules, Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Covalent Small Molecules → Small Molecules, RNA Therapeutics → Nucleic Acid Therapeutics, Classical Binding Small Molecules → Small Molecules
Administration: Parenteral

Overview

CAMYO-02 is a long non-coding RNA-based therapeutic vaccine under development by myNEO Therapeutics for the treatment of triple-negative breast cancer. It is classified as an antineoplastic, cancer vaccine, immunotherapy, and RNA vaccine. The mechanism of action involves immunostimulation—specifically, it acts as an immunostimulant to provoke or enhance the body's immune response against tumor cells. As of late 2023 and early 2025 updates, its highest development phase is preclinical research in Belgium for triple-negative breast cancer[1][2].

Targets

MHC-I-camyotope (MHC-I peptide-binding groove presenting camyotope peptides)TCR (T cell antigen receptor complex)

Beyond the preview

Go deeper on CAMYO-02.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAMYO-02.

Explore the full profile